Go to Content Go to Navigation Go to Navigation Go to Site Search Homepage

Research and Clinical Training


  • $1 million+ received in external funding 
  • 7 projects funded 
  • 5 presentations at national and international conferences 


“By uniting PPLM's nationally recognized research and training programs under the ASPIRE Center, we are leveraging our expertise to innovate across teams, connect with the communities we serve, and set policy and practice precedents across the country.” 

- MaryRose Mazzola, Director of the ASPIRE Center at PPLM

Research and Clinical Training

PPLM’s research and training programs, under the ASPIRE Center umbrella, improve clinical practices locally and nationally, inform future policies and advocacy efforts, fortify relationships with academic institutions to expand research networks, and help integrate research, education, and training into mainstream health care.


Keeping Score: Sex Education in Massachusetts and Beyond 

In FY23 PPLM launched the ASPIRE (Advancing Science and Practice through Innovations in Research and Education) Center for Sexual and Reproductive Health to promote excellence and equity in sexual and reproductive health. ASPIRE conducted an analysis of all 50 states and Washington, D.C. and assigned each of them a sex education score based on their support for or restrictions on sex education, LGBTQ+ rights, critical race theory, and social emotional learning. The data revealed that Massachusetts is lacking in sex education, placing it in the company of states which have some of the most restrictive laws on the books against abortion. The findings are being used to advocate for updated sex and relationship education guidelines for Massachusetts (see Education, Learning, and Engagement). 

The data was also used to identify eight target states with moderate sex ed policies, restrictive abortion policies, and sparse Get Real presence where PPLM’s Get Real: Comprehensive Sex Education That Works sexuality education curriculum for middle and high school aged youths can be expanded in the coming months. 


Researching the Impact of the Dobbs Decision   

ASPIRE’s legal research team, launched in January 2023, pursued the Minor Abortion Access Research and Advocacy Project (MAARAP), which assessed the ability of teens nationally to access safe and affordable abortion care in the post-Roe world. The analysis focused on the ways parental involvement laws, travel bans, and shield laws interact to create barriers to abortion care. The findings will be used to advocate for lowering barriers to abortion care for minors aged 16 and under in Massachusetts, as well as to advocate for protective policies for minors in other high-access states. 

Another study on the use of abortion services at PPLM immediately following the U.S. Supreme Court’s decision to overturn Roe v. Wade showed a 37.5% increase in the number of out-of-state abortion patients, which is about 45 additional abortions in the four months after Dobbs. The study also revealed a large increase in the use of charitable funding for abortion among non-resident patients. The findings signal Massachusetts’ growing importance as an abortion access state, as others implement abortion bans. 

ASPIRE also expanded the Quality and Equity in Abortion Seeking Travel (QuEAST) study to partner with clinics in southern Illinois and explore the barriers faced by marginalized young people who are crossing state lines to access abortion care. It’s examining the health impacts of abortion restrictions and how to better serve the needs of the most vulnerable abortion travelers.  


New Clinical Research Findings 

The clinical research team has focused their work on designing and participating in studies that expand abortion access while maintaining safety and efficacy; widening access to contraception; mitigating contraceptive side effects; and identifying the most effective methods of pain control during abortion and IUD procedures. One of the team’s ongoing projects is a multi-site investigation into the uses of the levonorgestrel IUD. This study, a collaboration with the University of Utah, is investigating the safety and effectiveness of levonorgestrel IUD insertion for emergency contraception within five days of sex, and the safety and effectiveness of insertion at any time during the menstrual cycle.  

Our team is also working with Teal Health on a study of a new device that would allow patients to collect their own samples for cervical cancer screening. The study will compare the samples collected by patients to those collected by their health care providers to determine whether patients’ self-collected samples are adequate for detection of high-risk human papillomavirus. If self-collected samples are adequate, we anticipate that these devices could expand access and reduce barriers to this important preventive care.   


A Pipeline for Sexual and Reproductive Health Practitioners  

The ASPIRE training team secured a grant from the Massachusetts Department of Public Health for the Advanced Practice Clinician Sexual and Reproductive Health (SRH) Residency program. Scheduled to launch in January 2024, this first-of-its-kind program will train physician assistant and nurse practitioner graduates in medication abortion and other health care services PPLM provides. With this initiative, PPLM is playing a crucial role in training the next generation of providers in the full spectrum of sexual and reproductive health care, including abortion.



Health Care 

Read Now


Read Now

Education, Learning and Engagement

Read Now

Research and Clinical Training

Read Now

Equity Initiatives

Read Now


Read Now


Read Now

This website uses cookies

Planned Parenthood cares about your data privacy. We and our third-party vendors use cookies and other tools to collect, store, monitor, and analyze information about your interaction with our site to improve performance, analyze your use of our sites and assist in our marketing efforts. You may opt out of the use of these cookies and other tools at any time by visiting Cookie Settings. By clicking “Allow All Cookies” you consent to our collection and use of such data, and our Terms of Use. For more information, see our Privacy Notice.

Cookie Settings

Planned Parenthood cares about your data privacy. We and our third-party vendors, use cookies, pixels, and other tracking technologies to collect, store, monitor, and process certain information about you when you access and use our services, read our emails, or otherwise engage with us. The information collected might relate to you, your preferences, or your device. We use that information to make the site work, analyze performance and traffic on our website, to provide a more personalized web experience, and assist in our marketing efforts. We also share information with our social media, advertising, and analytics partners. You can change your default settings according to your preference. You cannot opt-out of required cookies when utilizing our site; this includes necessary cookies that help our site to function (such as remembering your cookie preference settings). For more information, please see our Privacy Notice.



We use online advertising to promote our mission and help constituents find our services. Marketing pixels help us measure the success of our campaigns.



We use qualitative data, including session replay, to learn about your user experience and improve our products and services.



We use web analytics to help us understand user engagement with our website, trends, and overall reach of our products.